AXIM Biotechnologies, Inc.
AXIM
$0.003
$0.000.00%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -676.53% | 84.63% | -679.06% | 108.82% | -34.78% |
| Total Depreciation and Amortization | 0.09% | 1.12% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | 0.83% | 20.20% | 0.40% | 20.00% | -46.79% |
| Total Other Non-Cash Items | 711.01% | -86.34% | 208.43% | -133.75% | 42.72% |
| Change in Net Operating Assets | 233.96% | -258.51% | 181.84% | 2,052.00% | -103.35% |
| Cash from Operations | 151.82% | -5,544.39% | 107.41% | 58.90% | -353.24% |
| Capital Expenditure | 100.00% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -- | -- | -- | -- |
| Total Debt Issued | 0.00% | 0.00% | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -- | 6,543.80% | -92.80% | 68.92% | -35.66% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -163.72% | 788.48% | -40.22% | -72.34% | 363.97% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -51.93% | -144.82% | 279.27% | -268.86% | 598.41% |
